Cary Pharmaceuticals
About Cary Pharmaceuticals
Cary Pharmaceuticals is a pharmaceutical development company. The Company is advancing the development of QuitPak®, a patented treatment for smoking cessation, and a novel catheter lock solution to prevent clot formation in catheters. The Company is led by an experienced management team and Board of Directors, including Douglas Cary (President) a former Abbott Laboratories executing; Carl Schwan (CFO) a former CFO for two successful initial public offerings that raised $80 million; and Lester Crawford (Director), Former Commissioner of the U.S. Food and Drug Admininstration (FDA).
Company Facts
- Legal name: Cary Pharmaceuticals Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Website: carypharma.com
- Phone: (703) 759-7460
Social Profiles
Canonical: https://fsome.com/organization/cary-pharmaceuticals-8408637 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.